Room 2 — Controller Room 2 (컨벤션홀 2, 4F)

진행 중: —
--:--

세션 목록 (13개)

15:20~16:402026.04.30 (목)
Diabetes and metabolic dysfunction-associated steatotic liver disease Targeting the gut–liver axis in diabetes and MASLD: from mechanisms to novel therapeutics
예정
좌장: 정춘희 (연세원주의대 내과) · 조호찬 (계명대학교 동산의료원)
1
황유철 경희의대 내과 15:20-15:40
Diabetes and MASLD: shared mechanisms and therapeutic targets
2
임성묵 D&D pharmatech 15:40-16:00
Top-line phase 2 results of DD01, a dual GLP-1/Glucagon agonist: rapid improvements in liver and metabolic parameters in patients with MASLD/MASH
3
안재희 강원대 약대 16:00-16:20
Intestinal IL-22 signaling improves glucose homeostasis in obesity
PANEL
패널: 조계원 (순천향대 의생명연구원) · 임승순 (계명의대 생리학교실) · 하은영 (계명의대 내과) 16:20-16:40
16:50~17:502026.04.30 (목)
Latest diabetes technology Latest advances in diabetes technology: CGM, AID, and beyond
예정
좌장: 윤건호 (윤건호엔도내과) · 송기호 (건국의대 내과)
1
최훈지 한림의대 내과 16:50-17:05
What's new in AID
2
류영상 조선의대 내과 17:05-17:20
What's new in CGM
3
이다영 고려의대 내과 17:20-17:35
About continuous ketone monitoring (CKM)
PANEL
패널: 유승현 (가톨릭관동의대 내과) · 양여리 (가톨릭의대 내과) 17:35-17:50
08:00~08:152026.05.01 (금)
Breakfast symposium 2 The role of SGLT2i in CKM management
예정
좌장: 장학철 (서울의대 내과)
1
오태정 서울의대 내과 08:00-08:15
The role of SGLT2i in CKM management
08:15~08:302026.05.01 (금)
Breakfast symposium 4 Understanding iCGM: what it means and why it matters
예정
좌장: 이형우 (대구보훈병원)
1
허지혜 한림의대 내과 08:15-08:30
Understanding iCGM: what it means and why it matters
12:20~12:352026.05.01 (금)
Luncheon symposium 2 GLP-1 therapy for comorbidity management: evidence and clinical insights
예정
좌장: 유재명 (한림의대 내과)
1
김혜경 연세의대 내과 12:20-12:35
GLP-1 therapy for comorbidity management: evidence and clinical insights
14:00~15:202026.05.01 (금)
MASH: insulin resistance and inflammation From metabolic regulation to therapeutic innovation in MASH
예정
좌장: 이인규 (경북의대 내과) · 이대호 (시화병원 내과)
1
김하일 KAIST 14:00-14:20
Serotonin drives selective hepatic insulin resistance via HTR2A and HTR2B
2
임승순 계명의대 생리학교실 14:20-14:40
Regulatory mechanisms of LRH-1 as a therapeutic target for MASH
3
허진영 서강대 생명과학과 14:40-15:00
Tank-binding kinase 1 protects against MASH progression via mitochondrial quality control
PANEL
패널: 오병철 (가천의대 이길여암당뇨연구원) · 김경진 (인하의대 의생명학교실) · 이재민 (DGIST) 15:00-15:20
16:30~17:502026.05.01 (금)
Spatial omics & AI Next-generation diabetes research: AI and spatial multi-omics
예정
좌장: 송민호 (KAIST) · 최철수 (가천의대 내과)
1
박지환 GIST 16:30-16:50
Integrating single-cell and spatial multi-omics to map the pathological landscape
2
이상열 경희의대 내과 16:50-17:10
Linking clinical phenotypes with spatial omics: AI-driven patient stratification in diabetes
3
박준호 차의학전문대학원 의과학교실 17:10-17:30
Modern LC-MS-based proteomics for spatial omics
PANEL
패널: 강예은 (충남의대 내과) · 유은애 (고려대 생명과학부) · 김형석 (충남의대 내과) 17:30-17:50
08:00~08:152026.05.02 (토)
Breakfast symposium 6 TZD+SGLT-2i combination therapy : benefits for diabetic complications and MASLD
예정
좌장: 양태영 (태영21병원)
1
홍준화 을지의대 내과 08:00-08:15
TZD+SGLT-2i combination therapy: benefits for diabetic complications and MASLD
08:15~08:302026.05.02 (토)
Breakfast symposium 8 Managing residual atherogenic dyslipidemia in patients with type2 diabetes
예정
좌장: 윤석기 (천안엔도내과의원)
1
전자영 아주의대 내과 08:15-08:30
Managing residual atherogenic dyslipidemia in patients with type2 diabetes
09:00~10:202026.05.02 (토)
Meta-inflammation Meta-inflammation in metabolic disease: mechanisms to innovation
예정
좌장: 이종순 (순천향의생명연구원) · 오병철 (가천의대 이길여암당뇨연구원)
1
김효수 서울의대 내과 09:00-09:20
Mechanism of two different actions of PCSK9 through its receptor CAP1/cholesterol elevation in hepatocytes and inflammation in monocytes
2
조재호 전남의대 미생물학및면역학교실 09:20-09:40
Role of glucose uptake regulation in T cell homeostasis
3
김재범 서울대 생명과학부 09:40-10:00
Adipose tissue plasticity upon energy state
PANEL
패널: 이용호 (연세의대 내과) · 조계원 (순천향대 의생명연구원) · 조아라 (이화여대 생리학교실) 10:00-10:20
12:20~12:352026.05.02 (토)
Luncheon symposium 9 Why it matters: the only SGLT2i/DPP4i fixed-dose combination with original dapagliflozin
예정
좌장: 한경아 (을지의대 내과)
1
박찬호 동아의대 내과 12:20-12:35
Why it matters: the only SGLT2i/DPP4i fixed-dose combination with original dapagliflozin
12:35~12:502026.05.02 (토)
Luncheon symposium 13 Optimal clinical approach to combination use of SGLT2i and DPP-4i in the management of T2D
예정
좌장: 김상진 (순천향의대 내과)
1
류영상 조선의대 내과 12:35-12:50
Optimal clinical approach to combination use of SGLT2i and DPP-4i in the management of T2D
14:00~15:202026.05.02 (토)
Mechanism-driven combination strategy Evidence-based selection of "TZD, SGLT2i, and DPP4i combinations" for personalized and holistic patient management
예정
좌장: 박석원 (연세의대 내과) · 조재형 (가톨릭의대 서울성모병원)
1
김소헌 인하의대 내과 14:00-14:25
Efficacy & safety: maximizing weight neutrality and hypoglycemia prevention
2
서다혜 인하의대 내과 14:25-14:50
TZD+SGLT2i the ultimate duo: combining insulin sensitization with hemodynamic benefits
3
전재한 경북의대 내과 14:50-15:15
A dual mechanism for metabolic stability: revitalizing beta-cell function and peripheral sensitivity and summary